| abstract |
anti-pd-l1 antibodies, their production process, isolated nucleic acid, vector, host cell, kit, and pharmaceutical composition. the present patent application relates to anti-pd-l1 antibodies or antigen-binding fragments thereof, nucleic acid encoding them, therapeutic compositions thereof and their use to increase t cell function to up-regulate immune responses cell-mediated and for the treatment of dysfunctional t-cell disorders, such as tumor immunity, for the treatment of cancer. |